Meyka Pro banner
Rite Aid Corporation

Rite Aid Corporation (RAD) Stock Overview

Explore Rite Aid Corporation’s financial performance, market position, analyst ratings, and future outlook.

RADNYSE
HealthcareMedical - Pharmaceuticals
$0.65
$0.13(16.81%)
U.S. Market opens in 11h 44m

Rite Aid Corporation (RAD)

Meyka AI Score

Z

Key Financials

Market Cap36.8M
P/E Ratio-0.05
EPS (TTM)$-14.34
ROE2.76%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

RAD Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Rite Aid Corporation (NYSE: RAD) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Rite Aid Corporation's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of RAD on the NYSE shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NYSE listing.

Key metrics behind Rite Aid Corporation's NYSE-traded stock include a P/E ratio of -0.05 and a market capitalization of 36.8M. Combined with our AI analysis, these give both institutional and retail investors a clear view of RAD on the NYSE.

Price Performance (NYSE: RAD)

1-Day Change
N/A
5-Day Change
170.13%
1-Month Change
-16.81%
3-Month Change
-71.94%
6-Month Change
-65.15%
Year-to-Date (YTD) Change
-80.59%
1-Year Change
-89.03%
3-Year Change
-94.44%
5-Year Change
-97.51%
All-Time (Max) Change
-97.62%

Contact Information

17177612633
1200 Intrepid Avenue, Philadelphia, PA, NaN

Company Facts

470,000 Employees
IPO DateMar 17, 1980
CountryUS

Frequently Asked Questions